Trials / Recruiting
RecruitingNCT06506630
Effects of Coenzyme Q10 Supplement on Cardiovascular Risk Factors in Subjects at High Risk of Metabolic Syndrome
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Tian Zezhong · Academic / Other
- Sex
- All
- Age
- 30 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the ameliorating effect of coenzyme Q10 supplementation on cardiovascular risk factors in high risk population for metabolic syndrome, including blood lipid metabolism, insulin resistance, blood pressure regulation, platelet function, endothelial function, cardiorespiratory fitness and muscle function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | coenzyme Q10 | 300 mg capsule twice a day |
| DIETARY_SUPPLEMENT | placebo | 300 mg capsule twice a day |
Timeline
- Start date
- 2023-09-11
- Primary completion
- 2024-12-30
- Completion
- 2024-12-30
- First posted
- 2024-07-17
- Last updated
- 2024-07-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06506630. Inclusion in this directory is not an endorsement.